Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatrogon in Adult Growth Hormone Deficiency
NCT01909479Phase 3Terminated
- Sponsor
- OPKO Health
- Start
- Jun 2013
- Primary completion
- Aug 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of somatrogon in growth hormone deficiency (GHD), sponsored by OPKO Health. Started Jun 2013; status: terminated.
02
Drugs
somatrogon
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01909479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01909479.